MYOZ1 and myopathy: Pathway analysis of the DEGs underscored changes in the myopathy muscles, including biophysiological pathways like muscle contraction, lipoatrophy, myotube cell involvement, and FATZ (filamin-, α-actinin-, and telethonin-binding protein of the Z-disk) binding (Supplementary Fig. 4).